Pricing Log in Create free account
Saturday 17 October 2026 Export AMGN’s income statement to Excel — free account

Amgen Inc.

AMGN Healthcare Drug Manufacturers General

Amgen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $36.8 billion, up 9.95% from fiscal 2024. In the quarter to June 2026, revenue grew 9.53%, EPS grew 65.4%, free cash flow grew 82.6% and total debt rose 1.96%, each against the same quarter a year earlier. Member of the S&P 500, Nasdaq 100 and Dow Jones; dividend growth for ten consecutive years, revenue growth for five.

432.49 1.54 −0.35%
Market cap
$234.7B
P/E
26.7×
Fwd P/E
22.7×
Dividend yield
2.30%
F-score
7/9
Altman Z
1.69
Beneish M
−2.27
Dividend safety
56/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Amgen Inc. (AMGN) Book value per share

Alert me on Book value per share

Amgen Inc.'s book value per share at the end of fiscal 2025 was 16.1×, up 47.0% from 10.9× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 21.6×. Over the past ten years it has ranged from 6.8× (fiscal 2022) to 39.9× (fiscal 2016); the current reading is higher than 64% of that period. Amgen Inc. ranks 7th of 21 Drug Manufacturers General companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 16.1× 47.05%
FY2024 10.9× (6.05%)
FY2023 11.6× 71.18%
FY2022 6.8× (42.11%)
FY2021 11.8× (26.79%)
FY2020 16.1× 0.42%
FY2019 16.0× (15.45%)
FY2018 18.9× (45.23%)
FY2017 34.5× (13.55%)
FY2016 39.9× 7.80%

Quarterly newest first

Period Book value per share Change
Jun 2026 21.6× 27.18%
Mar 2026 17.0× 5.75%
Dec 2025 16.1× (9.99%)
Sep 2025 17.9× 29.50%
42 more quarters

Against its own ten years

Low 6.8× High 39.9×
Ten-year median 16.1×
Current reading's percentile 64

Book value per share against peers

Company Book value per share
AZN AstraZeneca PLC compare 32.5×
NVS Novartis AG compare 22.0×
AMGN Amgen Inc. 21.6×
MRK Merck & Co., Inc. compare 17.0×
PFE Pfizer Inc. compare 15.0×
BMY Bristol Myers Squibb Company compare 10.9×
GILD Gilead Sciences, Inc. compare 9.4×
NVO Novo Nordisk A/S compare 7.8×
ABBV AbbVie Inc. compare −3.3×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on AMGN